awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35158520-E0D7100F-FEBF-44CE-8DF8-4B97235F7DDC
Q35158520-E0D7100F-FEBF-44CE-8DF8-4B97235F7DDC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35158520-E0D7100F-FEBF-44CE-8DF8-4B97235F7DDC
Results on efficacy and safety of cancer treatment with or without tumor necrosis factor-related apoptosis-inducing ligand-related agents: A meta-analysis.
P2860
Q35158520-E0D7100F-FEBF-44CE-8DF8-4B97235F7DDC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35158520-E0D7100F-FEBF-44CE-8DF8-4B97235F7DDC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4e855e3c75e22b6b3abfa95ef2d88b4a7e0a3fc
P2860
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.